Study says companies spend $100 million to promote blockbuster drugs

A study by Cutting Edge Information, Driving Successful Pharma Brands: Case Studies of Real Product Launches, said companies promoting blockbuster products routinely spend over $100 million on commercialization from Phase 3 through the first year that the product is publicly available.

March 15, 2009

4:48 pm

A study by Cutting Edge Information, Driving Successful Pharma Brands: Case Studies of Real Product Launches, said companies promoting blockbuster products routinely spend over $100 million on commercialization from Phase 3 through the first year that the product is publicly available. The study said Lilly will need an aggressive campaign for Prasugrel to compete with Bristol-Myers Squibb/Sanofi-Aventis’s Plavix in Europe, where the delayed-in-the-US Lilly drug won approval.

From the April 01, 2009 Issue of MM+M - Medical Marketing and Media

From Our Partners

Prioritizing audience quality and contextual environment in POC marketing

Partner Content

Prioritizing audience quality and contextual environment in POC marketing

Despite the growing popularity of POC marketing via EHR platforms, this channel remains highly fragmented. For omnichannel marketers, that fragmentation can represent challenges in finding scale, transparency, and uniformity in targeting and performance reporting.

Want to better engage patients with complex diagnoses? Embrace digital.

Partner Content

Want to better engage patients with complex diagnoses? Embrace digital.

Patients often struggle to find specialist care, delaying needed treatment. Digital tools can help.

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.